A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products.
Other Bill Titles (1 more) 11/14/2007--Introduced.
Amends the Internal Revenue Code to allow a general business tax credit for 50% of expenses paid for research and development of any qualified infectious disease product. Defines "qualified infectious disease product" as any antibiotic drug, antiviral,... moreSee Full Bill Text
Committees
Amendments
This bill has no amendments.
Bill Status
| Introduced | ![]() | Voted on by Senate | ![]() | Voted on by House | ![]() | Considered By President | ![]() | Bill Becomes Law |
| November 14, 2007 |
In the News
We are not currently finding any news articles on this topic using our daily automated search of Google News. However, if you know of a relevant news article to display here, OpenCongress site editors have the ability to add it manually. Simply e-mail us the web address of this page and the web address of your suggested news article: We'll post relevant links as quickly as possible. Also, if this topic is important to you, you could write a letter to the editor -- if a news article refers this specific topic by name, a link to that news article is likely to appear here soon.
Blog Coverage
November 13, 2007 Bill Action: Introduced: S. 2351: A bill to amend the Internal ...
Charles Schumer [D-NY] introduced S. 2351: A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products. [This event matched these trackers: ...
November 13, 2007 S. 2351, A bill to amend the Internal Revenue Code of 1986 to ...
S. 2351 would amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products.... Vote on This Bill: For | Against.








Rating Filter: 5
(Close help)
Comments
(Close help)
No Comments
Add A Comment